Max India Limited has informed the Exchange about Transcript
MAXIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max India shared detailed updates across its three verticals—senior residences, Antara Assisted Care (AACS), and AGEasy products. A Rights Issue of INR124.23 crore was oversubscribed 1.45 times, and three floors of Max Towers were monetized for INR105.08 crore, strengthening the balance sheet. In residences, 90% of the Estate 360 Gurgaon inventory (260 of 292 units) has been sold with INR239 crore in collections. AACS net revenue reached INR65.2 crore (2–3x growth), crossing a INR100 crore annual run rate, while AGEasy revenue hit INR40.4 crore (3.6x growth). Consolidated FY25 revenue was INR164 crore with an EBITDA loss of INR37.2 crore, and the company holds INR250 crore in treasury and monetizable assets. Management indicated a possible second fundraising round later this year to support growth.
Strong topline momentum in care services and product business is positive, but consolidated EBITDA loss widened due to growth-stage marketing spend, which may weigh on near-term sentiment. Balance sheet is now well-capitalized for expansion, though a second equity raise flagged by management hints at potential dilution risk for existing shareholders.